Literature DB >> 28081982

Umbilical cord-derived mesenchymal stromal cell-conditioned medium exerts in vitro antiaging effects in human fibroblasts.

Meirong Li1, Yali Zhao1, Haojie Hao2, Liang Dong2, Jiejie Liu2, Weidong Han3, Xiaobing Fu4.   

Abstract

BACKGROUND AIMS: Chronic wounds are a common complication of diabetes. Fibroblast-myofibroblast differentiation is important for wound repair, which is commonly impaired in non-healing wounds, and the underlying mechanisms need to be further elucidated.
METHODS: We used high glucose (HG) to simulated the diabetes microenvironment and explored its effects on the biological features of fibroblasts in vitro.
RESULTS: The results showed that prolonged HG induced senescence in fibroblasts through activation of p21 and p16 in a reactive oxygen species (ROS)-dependent manner, further delayed the viability and migration in fibroblasts and also depressed fibroblast differentiation through the TGF-β/Smad signaling pathway. However, mesenchymal stromal cell-conditioned medium (MSC-CM) counteracts the effects of HG. Treatment of fibroblasts with MSC-CM decreased HG-induced ROS overproduction, ameliorated HG-induced senescence in fibroblasts and reversed the defects in myofibroblast formation. Our results may provide clues for the pathogenesis of chronic wounds and a theoretical basis to develop MSC-CM as an alternative therapeutic method to treatment of chronic wounds.
Copyright © 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic wounds; high glucose; mesenchymal stromal cell-conditioned medium; myofibroblast; oxidative stress; senescence

Mesh:

Substances:

Year:  2017        PMID: 28081982     DOI: 10.1016/j.jcyt.2016.12.001

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  7 in total

1.  Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.

Authors:  Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain
Journal:  Radiat Res       Date:  2017-06-12       Impact factor: 2.841

2.  Activated Mesenchymal Stromal Cell Therapy for Treatment of Multi-Drug Resistant Bacterial Infections in Dogs.

Authors:  Valerie Johnson; Lyndah Chow; Jacqueline Harrison; Sirikul Soontararak; Steven Dow
Journal:  Front Vet Sci       Date:  2022-06-23

3.  Anti-aging Properties of Conditioned Media of Epidermal Progenitor Cells Derived from Mesenchymal Stem Cells.

Authors:  Su Ji Sohn; Ji Min Yu; Eun Young Lee; You Jin Nam; Jinwan Kim; Sukho Kang; Dong Hyun Kim; Aeri Kim; Sangjin Kang
Journal:  Dermatol Ther (Heidelb)       Date:  2018-03-02

4.  Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway.

Authors:  Xiaowei Bian; Bingmin Li; Jie Yang; Kui Ma; Mengli Sun; Cuiping Zhang; Xiaobing Fu
Journal:  Stem Cell Res Ther       Date:  2020-04-29       Impact factor: 6.832

5.  The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration.

Authors:  Jimena Cuenca; Alice Le-Gatt; Valentina Castillo; Jose Belletti; Macarena Díaz; Mónica Kurte G; Paz L Gonzalez; Francisca Alcayaga-Miranda; Christina M A P Schuh; Fernando Ezquer; Marcelo Ezquer; Maroun Khoury
Journal:  Front Physiol       Date:  2018-05-14       Impact factor: 4.566

6.  BMMSC-sEV-derived miR-328a-3p promotes ECM remodeling of damaged urethral sphincters via the Sirt7/TGFβ signaling pathway.

Authors:  Hanke Zhang; Jiayu Huang; Jiaying Liu; Yanhui Li; Ying Gao
Journal:  Stem Cell Res Ther       Date:  2020-07-16       Impact factor: 6.832

7.  Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells.

Authors:  Yan Zhang; Jia Xu; Siying Liu; Meikuang Lim; Shuang Zhao; Kaige Cui; Kaiyue Zhang; Lingling Wang; Qian Ji; Zhongchao Han; Deling Kong; Zongjin Li; Na Liu
Journal:  Theranostics       Date:  2019-09-21       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.